Transforming Cancer Care Through Diagnostics and Personalized Medicine
The American Association for Cancer Research (AACR) and AdvaMedDx are hosting a diagnostics symposium to illustrate how scientific progress is enabling advances in the development of new molecular tests that are transforming cancer care and delivering on the promise of personalized medicine.
Featuring talks by leaders such as Francis Collins, M.D., Ph.D., director, National Institutes of Health; Margaret Hamburg, M.D., commissioner, U.S. Food and Drug Administration; Harold Varmus, M.D., director, National Cancer Institute; and many more, the symposium will highlight the current status and the future of cancer diagnostics, how they are changing our understanding of cancer biology and revolutionizing the way we treat and manage the various cancers. Panels will also discuss policy issues impacting patient access to innovative diagnostics.
PROGRAM OUTLINE 8:30 a.m. - 4 p.m.
Why Diagnostics Matter
The State of Genomic Understanding
Detection and Prognosis: The Cutting Edge
The Path to Personalized Medicine - Where Are We Today?
Ensuring Patient Safety and Innovation
Ensuring Patient Access to Innovative Diagnostics
Grand Hyatt Washington
1000 H St NW, Washington, DC 20001
REGISTRATION IS FREE! RSVP below.